Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on April 29, 2010, to report its financial results for the first quarter of 2010. The filing itself does not contain the detailed financial data but rather references a press release (Exhibit 99.1) and supplemental information posted on the company's website (Exhibit 99.2) as the primary sources of this information. Investors should refer to these accompanying documents for specifics on revenue, earnings, and other key financial performance indicators for the quarter ending April 28, 2010. While the 8-K doesn't provide the numbers directly, its purpose is to formally announce the earnings release and make the associated information publicly available through SEC channels. This ensures transparency and compliance with reporting requirements. Investors interested in BMY's performance during Q1 2010 need to examine the press release and supplemental materials for a comprehensive understanding of the company's financial health and operational outcomes.
Key Highlights
- 1BMY filed an 8-K on April 29, 2010, to report its Q1 2010 financial results.
- 2The primary financial information is contained in an attached press release (Exhibit 99.1).
- 3Supplemental financial data is also available on the company's website (Exhibit 99.2).
- 4The filing serves as formal notification of the Q1 2010 earnings release.
- 5No specific financial figures are detailed within the 8-K document itself.
- 6Investors must consult the referenced press release and supplemental information for Q1 2010 performance details.